Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 817 results for "iias"

A Very Slippery Business

Essar Oil Delisting: IiAS Votes In Favour

With a fortnight to go before shareholders decide on the delisting of Essar Oil from equity markets, proxy advisory firm Institutional Investor Services of India (IiAS) has come out with a report advising ... Businessworld India, 4 days ago
A Very Slippery Business, 6 days ago

154 images for iias, 10 hours ago
MSN Living, 2 hours ago
Daily Mercury News, 11 hours ago
Business Insider, 6 days ago
Business 2 Community, 1 week ago
CNN, 2 weeks ago
Proactive, 1 week ago
Bioresearch Online, 2 weeks ago
WireNews, 2 weeks ago
Santa Clarita Valley Signal, 2 weeks ago
Money Control

Cairn's $1.25bn loan to Vedanta: 3 key questions unanswered

Raising concerns of adequate cash utilization Hetal Dalal, COO of proxy firm Investor Advisory Services India Ltd (IiAS) is concerned by the levels of disclosure made by the company with respect to this transaction
 Money Control5 days ago
Times of India

Infosys: All for Vishal Sikka's fat paycheck, but…

Proxy advisory firm IiAS has recommended shareholders to vote the proposal to appoint Vishal Sikka as Infosys' MD & CEO and also fix his annual remuneration at a maximum of Rs42.5 crore. But IiAS is also raising some concerns Infosys Ltd, India's ...
 Money Life1 week ago Proxy firms back Infosys CEO designate Vishal Sikka's over $7 million pay package  Economic Times1 week ago Proxy firms back Vishal Sikka's $7 mn pay at Infosys  Economic Times1 week ago Vishal Sikka's salary to spark IT payhike  Deccan Chronicle1 week ago

IiAS frowns upon Coal India’s diversification

The government of India’s plan for Coal India Ltd to diversify into fertiliser production has met with resistance from the Institu-tional Investor Advisory Services India Limited (IiAS) a proxy advisory firm. Coal India at the behest of the GoI plans to ...
 Asian Age4 weeks ago

Gopalkrishna Gandhi quits Kalakshetra, IIAS

Confirming his resignation, Gandhi, a former administrator and diplomat, said the move was "in keeping with the convention followed during a change of government". While IIAS was set up by the ministry of education, Kalakshetra Foundation is part of the ...
 Economic Times2 months ago Gopalkrishna steps down as chairman of Kalakshetra, IIAS  The Hindu2 months ago Gopalkrishna resigns from Shimla research institute  Sify2 months ago

5 things you need to know about auditor remuneration: IiAS

The Companies Act 2013 requires statutory auditors’ fees to be set in the company’s annual general meeting. Yet, most of the resolutions regarding auditor remuneration, when presented to shareholders for a vote, only ask shareholders to empower the board ...
 Money Control2 months ago

Mahatma Gandhi's grandson quits top post of IIAS

Shimla, May 21 : Grandson of Mahatma Gandhi Gopalkrishna Gandhi today quit the top post of Indian Institute of Advanced Study after BJP leader Narendra Modi was elected to the Prime minister's post. Spokesman of IIAS told UNI that Mr Gopalkrishna Gandhi, who ...
 New Kerala2 months ago Mahatma Gandhis grandson quits top post of IIAS  Himvani2 months ago
New New Internet

Contracts for July 29, 2014

CONTRACTS U.S. TRANSPORTATION COMMAND National Air Cargo Group, Inc., Orlando, Florida, is being awarded a $513,625,650 maximum ceiling modification (P00013), exercising the second option period to previously awarded contract ...
 United States Department of Defense53 minutes ago NASA Gives MSES II/A Contract Extension to Stinger Ghaffarian  Individual.com6 days ago NASA Awards MSES II/A Contract Extension to Stinger Ghaffarian  Individual.com1 week ago NASA Extends Engineering Services Contract with Stinger Ghaffarian Technologies  New New Internet2 weeks ago

Cardioxyl Pharmaceuticals successful first clinical trial for heart failure drug CXL-1427

Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers. The company ...
 Cardiovascular Business4 hours ago Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF  News-Medical.Net1 day ago

Update: LPath Clinical Trial Results

Summary ASONEP data helps to reaffirm investor confidence in the ASONEP program. I reiterate previous article and still consider LPath to be a compelling buy. ASONEP trial expansion will give investors a clearer picture as the company moves ...
 Seeking Alpha6 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less